Sign In

Chris Gibson

Co-Founder/CEO Recursion: a biotech scaling more like a tech company - Nasdaq:RXRX | Reimagining the Future of Biotech

Chris Gibson is a highly accomplished individual with a strong background in bioengineering, entrepreneurial studies, and medicine.

He is the founder and CEO of Recursion, a pioneering digital biology company focused on revolutionizing drug discovery through the fusion of automation, artificial intelligence, and biological data.

Under his leadership, Recursion has advanced numerous clinical-stage and pre-clinical programs across various therapeutic areas, aiming to accelerate the development of life-changing medicines.

With a Ph.D. in Bioengineering from the University of Utah and a Doctor of Medicine degree, Chris brings a unique blend of scientific expertise and business acumen to his endeavors.

He is dedicated to leveraging technology and innovation to drive advancements in medicine, aiming to improve patient outcomes and reduce healthcare costs.

In addition to his work at Recursion, Chris is actively involved in mentoring and supporting emerging biotech entrepreneurs, demonstrating his commitment to nurturing the next generation of scientific innovators.

Highlights

Feb 19 · TechCrunch
NIH funding uncertainty spurs new biotech venture fund
NIH funding uncertainty spurs new biotech venture fund
Jun 25 · Benzinga
Recursion Pharmaceuticals Stock Is Moving Tuesday: What's Happening? - Recursion Pharmaceuticals (NASDAQ ... - Benzinga
Recursion Pharmaceuticals Stock Is Moving Tuesday: What's Happening? - Recursion Pharmaceuticals (NA
Chris Gibson
Add to my network

Location

Salt Lake City, Utah, United States